Despite an increase in government funding and a wider expansion of healthcare interventions in the country, Burkina Faso continues to face health challenges, particularly in the form of communicable diseases. Malaria is highly endemic in Burkina Faso and highly seasonal; most malaria cases and deaths in under-fives occur during the rainy season, and the country accounts for four percent of malaria deaths worldwide. We work closely with the Ministry of Health in addressing this through our seasonal malaria chemoprevention (SMC) programme. The success of SMC in Burkina Faso has enabled us to explore additional opportunities to support some of the country's most pressing health needs.
Malaria Consortium established an office in Ouagadougou, the capital of Burkina Faso, in December 2014 as part of the ACCESS-SMC project and have continued to deliver seasonal malaria chemoprevention (SMC) projects in the country since then. In 2021, Malaria Consortium supported SMC in 27 health districts across six regions of Burkina Faso, to reach approximately 1.9 million children under five.
We work with government and implementing partners to plan campaigns, increase community engagement, distribute antimalarials and undertake operational research to provide technical advice and the necessary evidence for the Ministry of Health and other partners to make informed decisions about adaptation and innovation in SMC at regional and national levels. We have also begun to explore the potential of digital solutions to strengthen health systems in the country.